Search results
Moderna (NASDAQ:MRNA) PT Raised to $106.00
ETF DAILY NEWS· 5 days agoModerna (NASDAQ:MRNA – Free Report) had its price target increased by Canaccord Genuity Group from $91.00 to $106.00 in a report published on Friday, Benzinga reports. Canaccord ...
Moderna director Noubar Afeyan sells over $1.8m in company stock By Investing.com
Investing.com· 1 day agoModerna , Inc. (NASDAQ:MRNA) director Noubar Afeyan has recently sold a significant amount of...
Positive week for Moderna, Inc. (NASDAQ:MRNA) institutional investors who lost 6.8% over the past...
Simply Wall St. via Yahoo Finance· 3 days agoKey Insights Significantly high institutional ownership implies Moderna's stock price is sensitive...
Unveiling Moderna (MRNA)'s Value: Is It Really Priced Right? A C
Guru Focus· 6 days agoToday, Moderna Inc (MRNA, Financial) experienced a stock price decline of 3.43%, yet it has seen a significant three-month gain of 28.21%. With a current ...
Moderna, Inc. (NASDAQ:MRNA) Shares Sold by Russell Investments Group Ltd.
ETF DAILY NEWS· 3 days ago(NASDAQ:MRNA – Free Report) by 28.3% during the 4th quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The firm owned 67,054 ...
Is Moderna Stock A Buy On Its Eye-Popping First-Quarter Sales Beat?
Investor's Business Daily· 4 days agoSales are expected to accelerate in a big way in the third quarter, with a projected $1.47 billion,...
What's Going With Moderna Stock On Friday? - Moderna (NASDAQ:MRNA)
Benzinga· 2 days agoThe Food and Drug Administration (FDA) notified Moderna Inc MRNA on Friday that its review of a new vaccine has been delayed. The agency, citing administrative constraints ...
Insider Sale Alert: Moderna Inc [MRNA] – Is it Time to sell? – Knox Daily
Knox Daily· 5 days agoA total of 3.94 million shares were traded, compared to the trading of 11.97 million shares in the previous session. Levels Of Support And Resistance For MRNA Stock ...
Moderna Inc (MRNA)'s Uncertain Future: Understanding the Barrier
Guru Focus· 6 days agoLong-established in the Biotechnology industry, Moderna Inc (MRNA, Financial) has enjoyed a stellar reputation. Notably, its diminished rankings in financial strength, growth ...
Moderna’s mRNA dreams meet reality with first post-COVID shot - The Boston Globe
The Boston Globe· 2 days agoModerna’s stock dropped 45 percent last year, making it the worst-performing large biotech in the...